Try our Advanced Search for more refined results
Pinckney Weidinger
-
Order | Filed: May 13, 2024 | Entered: May 13, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Oral Order 1 - Terminate Hearings
ORAL ORDER: The Court has considered the parties discovery dispute letters. (No. 20-2930, D.I. 1354, 1358). MSNs request to compel production of testing records is DENIED. The conference scheduled for 5/15/2024 is CANCELED. Defendant has not waived the work product privilege that protects the relevant testing data from discovery. Novartis decision to withdraw infringement allegations in an earlier case does not qualify as using privilege as a sword. In addition, the testing records appear to be shielded from discovery by the stipulated protective order. (See 20-2930, D.I. 80 50). Ordered by Judge Richard G. Andrews on 5/13/2024. Associated Cases: 1:20-md-02930-RGA, 1:22-cv-01395-RGA(nms)
-
Discovery | Filed: May 13, 2024 | Entered: May 13, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of Opening Expert Report of Dr. Francis G. Spinale on the Infringement of the '667 Patent by Gerbera Therapeutics, Inc. and Nanjing Noratech Pharmaceutical Co., Limited filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
-
Discovery | Filed: May 13, 2024 | Entered: May 13, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Notice of Service
NOTICE OF SERVICE of (1) Opening Expert Report of Adam J. Matzger, Ph.D. on Infringement of U.S. Patent No. 11,096,918 by Nanjing Noratech Pharmaceutical Co., Limited and Gerbera Therapeutics, Inc., and (2) Expert Report of Aeri Park, Ph.D. on U.S. Patent No. 11,096,918 filed by Novartis Pharmaceuticals Corporation.(Joyce, Alexandra)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login